Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia, Myeloid, Acute 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Myelodysplastic Syndromes 16Hodgkin Disease 13Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 8Lymphoma 8Leukemia, Biphenotypic, Acute 8Leukemia 8Burkitt Lymphoma 7Breast Neoplasms 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Neoplasms 5Multiple Myeloma 5Lymphoma, Mantle-Cell 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Triple Negative Breast Neoplasms 4Sarcoma 4Rhabdomyosarcoma 4Medulloblastoma 4Lymphoma, Follicular 4Anemia, Refractory, with Excess of Blasts 4Leukemia, Myelomonocytic, Chronic 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Myeloproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

Carboplatin 9pembrolizumab 7Pemetrexed 7Radiotherapy 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Radiation 4Nivolumab 4Bevacizumab 4Platinum 3Paclitaxel 3Mastectomy, Segmental 3Cisplatin 3Biopsy 3fludarabine phosphate 2durvalumab 2capmatinib 2aldesleukin 2Taxes 2Radiotherapy, Conformal 2Radiosurgery 2Ipilimumab 2Interleukin-2 2Immunoglobulin G 2Disulfides 2Cyclophosphamide 2CTLA-4 Antigen 2Anterior Temporal Lobectomy 21,2-diaminocyclohexaneplatinum II citrate 2veliparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Filgrastim × 1 year × Clear all
NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
29 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡